Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | CTSB | P07858 | 1/20 | 0.57 |
| ▸ | CTSH | P09668 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | CCR1 | P32246 | 2/20 | 0.44 |
| ▸ | CCR5 | P51681 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3275602 | 0.87 | KMT2A (0.77) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL7171554 | 0.85 | KMT2A (0.74) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL28898898 | 0.83 | KMT2A (0.71) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL6177657 | 0.82 | KMT2A (0.69) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL31186674 | 0.82 | KMT2A (0.69) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL4703454 | 0.80 | KMT2A (0.67) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL1461144 | 0.80 | KMT2A (0.67) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL7692195 | 0.80 | KMT2A (0.67) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL4286016 | 0.79 | KMT2A (0.65) | KMT2AOPRK1CTSBCTSHHTT | |
| SCHEMBL4304569 | 0.79 | KMT2A (0.65) | KMT2AOPRK1CTSBCTSHHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240299400-A1 | Transcription Factor GLI1 Inhibitors and Uses Thereof | UNIVERSITY OF CONNECTICUT (US) | 2024-09-12 | — | — | US | disclosed |
| US-9601704-B2 | Organic light-emitting device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-03-21 | — | — | US | disclosed |
| US-9466804-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20150364703-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150357587-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150333279-A1 | ORGANIC LIGHT-EMITTING ELEMENT AND DISPLAY APPARATUS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-11-19 | — | — | US | disclosed |
| US-6140341-A | FOR TREATING PAIN | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-10-31 | — | — | US | disclosed |
| EP-0795547-B1 | (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists | HOECHST AG (DE) | 2000-05-10 | — | — | EP | disclosed |
| EP-0795547-A1 | (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299400-A1 | Transcription Factor GLI1 Inhibitors and Uses Thereof | GLI1, GLI2, SHH | KMT2A 680/4885OPRK1 4580/4885CTSB 2337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.